SupplySide West 2024: Novonesis spotlights women’s health and mental health probiotics
11 Nov 2024 | Novonesis
At SupplySide West 2024, Novonensis featured the breadth of its entire portfolio, with a particular focus on women’s health across all life stages. Among highlights are LGG, its Lactobacillus rhamnosus probiotic, alongside its ProbioBrain mental wellness solution. Jakob Dalmose Rasmussen, VP of Human Health, touches on the company’s trend-driven plans following its transition as a merger between Chr Hansen and Novozymes.
Upcoming webinars

Bifidobacteria and Healthy Ageing: New Insights into Ageing and Immunity
Morinaga

The future of infant nutrition: From science to success
Valio

From tiny guts to big impact: the powerful potential of probiotics in children’s health
Novonesis

















